XML 140 R72.htm IDEA: XBRL DOCUMENT v3.25.0.1
Fair Value Measurements - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Investments in unconsolidated subsidiaries, fair value       $ 378.0 $ 352.0  
Estimated fair value of investment       9.0    
Asset impairments     $ 10.0 0.0 0.0 $ 59.0
Goodwill, impairment loss $ 22.0          
Total long-term debt       3,320.0 2,855.0  
2.500% senior notes | Carrying Value | Notes Payable on Real Estate            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Total long-term debt       196.0 124.0  
Real Estate Investments            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Goodwill, impairment loss $ 22.0 $ 26.0        
Fair Value Measured at Net Asset Value Per Share | Recurring            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Investments at fair value using NAV       21.0 19.0  
Non-Marketable Equity Investments            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Capital investments       $ 148.0 143.0  
Raleigh Joint Venture            
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]            
Remeasurement gain         $ 34.0  
Percentage of remeasuring investment in previously unconsolidated subsidiary         50.00%  
Equity interest percentage         50.00%  
Fair value of investment in unconsolidated subsidiary at acquisition date         $ 37.0